Yasemin PARLAKDidem GÖKSOYGözde MÜTEVELİZADEGül GÜMÜŞERElvan SAYIT2024-07-242024-07-2420192619-9793http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/22497Introduction: The aim of the study was to define the baselineSUVmax range in the liver and blood pool of patients undergoingfluorodeoxyglucose-positron emission tomography/computedtomography (FDG-PET/CT) imaging.Methods: Five hundred and thirty-one patients (264 females,267 males; mean age: 59.6±13.4 years) who were admittedto our department for PET/CT imaging before treatmentwere included in the study. Patient preparation, acquisitionparameters and reconstruction protocols were standardized forall patients prior to PET/CT imaging. The mean serum glucoselevels and mean age of the patients were calculated. Thesepatients were divided into 10 groups as esophagus, stomach,colon, rectum, larynx, lung, breast, endometrium, ovariancancers and lymphoma. 2D region of interests were plotted tocalculate the mean SUV values in the right lobe of the liver andthe aortic arch for the blood pool.Results: Normal Gaussian distributions of mean SUV changesfor liver and blood pool were obtained. Mean SUVmax and SUVmeanvalues for liver were 2.73±0.22 and 2.34±0.16, respectively,and 1.80±0.2 and 1.57±0.14 for blood pool, respectively.Conclusion: It was concluded that the obtained SUV rangesmay provide ease of application in the clinic in evaluatingqualitative tumor response and comparing tumor/backgroundratios in cancer patients.eng[Fen > Tıp > Tıbbi Araştırmalar Deneysel, Fen > Tıp > Genel ve Dahili Tıp]Araştırma Makalesi10.4274/imj.galenos.2019.43255